Literature DB >> 33189418

Alpha-1 Antitrypsin Deficiency and COVID-19 Infection.

Michael Strassmair1, Manfred Stangl2.   

Abstract

Year:  2020        PMID： 33189418      PMCID： PMC7577864          DOI： 10.1016/j.arbres.2020.10.009

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  5 in total

1.  Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

Authors:  Shutoku Matsuyama; Makoto Ujike; Shigeru Morikawa; Masato Tashiro; Fumihiro Taguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

2.  Geographical Overlap Between Alpha-1 Antitrypsin Deficiency and COVID-19 Infection in Italy: Casual or Causal?

Authors:  Andrea Vianello; Fausto Braccioni
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-05-31       Impact factor: 4.872

3.  Lysosomal Proteases Are a Determinant of Coronavirus Tropism.

Authors:  Yuan Zheng; Jian Shang; Yang Yang; Chang Liu; Yushun Wan; Qibin Geng; Michelle Wang; Ralph Baric; Fang Li
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

4.  Characterization of the Inflammatory Response to Severe COVID-19 Illness.

Authors:  Oliver J McElvaney; Natalie L McEvoy; Oisín F McElvaney; Tomás P Carroll; Mark P Murphy; Danielle M Dunlea; Orna Ní Choileáin; Jennifer Clarke; Eoin O'Connor; Grace Hogan; Daniel Ryan; Imran Sulaiman; Cedric Gunaratnam; Peter Branagan; Michael E O'Brien; Ross K Morgan; Richard W Costello; Killian Hurley; Seán Walsh; Eoghan de Barra; Cora McNally; Samuel McConkey; Fiona Boland; Sinead Galvin; Fiona Kiernan; James O'Rourke; Rory Dwyer; Michael Power; Pierce Geoghegan; Caroline Larkin; Ruth Aoibheann O'Leary; James Freeman; Alan Gaffney; Brian Marsh; Gerard F Curley; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2020-09-15       Impact factor: 21.405

5.  Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia.

Authors:  Yingxin Zhang; Jie Ding; Shaoda Ren; Weihua Wang; Yapei Yang; Shuangjing Li; Min Meng; Tiejun Wu; Daliang Liu; Suochen Tian; Hui Tian; Shuangfeng Chen; Changhui Zhou
Journal:  Stem Cell Res Ther       Date:  2020-05-27       Impact factor: 6.832
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.